Fecal microbiota transplantation for overweight women with PMOS undergoing embryo transfer
Official title: Fecal Microbiota Transplantation for the Treatment of Polyendocrine Metabolic Ovarian Syndrome in Obese Women:A Phase Ⅰ/ⅡSingle-Arm Pilot Study and Planned Randomized Controlled Trial
Run by Shanghai Changzheng Hospital · NCT07746635 · Data updated 2026-11-12
We are testing if oral FMT capsules are safe and can improve pregnancy outcomes for overweight/obese women with PMOS undergoing frozen embryo transfer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | Women only |
| Enrollment | 411 (estimated) |
| Sponsor | Shanghai Changzheng Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | April 15, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07746635 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 20-40 with PMOS, BMI ≥ 24 kg/m2, scheduled for FET, and willing to participate.
✕Probably not a fit
Individuals outside the PMOS spectrum, with BMI below 24, or not undergoing FET may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial tests oral fecal microbiota transplantation (FMT) capsules in overweight or obese women with Polyendocrine Metabolic Ovarian Syndrome (PMOS) who are having a frozen-thawed embryo transfer. It consists of two stages: a small, open-label pilot to assess safety and preliminary effects on gut microbiota and pregnancy outcomes, followed by a larger randomized controlled trial to confirm efficacy against standard care or placebo. The study measures safety, metabolic and endocrine changes, and reproductive outcomes, with Phase 2 designed to validate mechanisms identified in Phase 1. The intervention uses freeze-dried oral FMT capsules and compares them to a control in a multicenter setting after initial single-center exploration.
Why it matters
Potential benefit: If successful, participants may experience improved reproductive outcomes and metabolic/endocrine health related to PMOS.
How similar studies have gone: This approach is exploratory; similar FMT strategies have shown potential in metabolic conditions but direct success in PMOS-related fertility is not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Females aged 20 to 40 years old. * 2\. Meeting the diagnostic criteria for Polyendocrine Metabolic Ovarian Syndrome (PMOS). * 3\. Body Mass Index (BMI): \>24.0 kg/m²(covering overweight and obese patients according to Asian criteria, addressing the actual recruited cohort ranging from 24.0 kg/m² upwards). * 4\. Scheduled to undergo Frozen-Thawed Embryo Transfer (FET) at the Reproductive Medicine Center. * 5\. Voluntary participation with signed Informed Consent Form (ICF). Exclusion Criteria: * Age \< 20 or \> 40 years. * Pregnancy or lactation. * Other endocrine disorders (e.g., Cushing's syndrome, thyroid dysfunction); severe organ dysfunction or impaired intestinal mucosal barrier; use of antibiotics, probiotics, or prebiotics within 1 month. * Use of ovulation-modifying or anti-androgen drugs within 3 months; severe psychiatric disorders. * Concurrent participation in other clinical trials.
Where it's running
-
Center for Reproductive Medicine,Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Ningxia Sun, MD-PhD — Shanghai Changzheng Hospital
- Study coordinator: Ningxia Sun, Chief
- Email: suesunchzh@126.com
- Phone: 13817975897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian drilling via vNOTES laparoscopy for PCOS patients
This study tests whether drilling the ovaries using vNOTES laparoscopy can help women with PCOS who did not respond to first-line medicines.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Lean Beef as Part of a Healthy Meal Plan for Adolescent Girls with PCOS/PMOS
This pilot study tests a lean beef–based meal plan to see if it improves blood sugar control and diet quality in adolescent girls with PCOS/PMOS.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Glp-1/FGF21 dual agonist for PCOS treatment
This study tests a GLP-1/FGF21 dual agonist to see if it helps women with PCOS by improving weight, hormones, and menstrual health.
-
Low-glycemic-index, high-fiber diet for women with PCOS in rural Yunnan
This 6-month program will test whether a culturally adapted low-glycemic-index, high-fiber diet can improve insulin resistance, hormone levels, and menstrual regularity in women with PCOS living in remote Yunnan.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.